ADRX Insider Trading Activity and SEC Form 4 Filings
ADRX insider trading summary
Over the past 12 months, insiders at ADARx Pharmaceuticals, Inc. (ADRX) reported 25 open-market purchases worth $152.3M by 9 insiders and no sales on SEC Form 4. Net insider buying was $152.3M.
Latest ADRX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 28, 2026 | Sr One Capital Management, LLC | Insider | Buy | $10.1M (592,593 @ $17.00) |
| Sep 28, 2026 | OrbiMed Israel GP II, L.P. | Director | Buy | $5.1M (300,249 @ $17.00) |
| Sep 28, 2026 | Simeon George | Insider | Buy | $10.1M (592,593 @ $17.00) |
| Sep 28, 2026 | Sr One Capital Management, LLC | Insider | Buy | $7.1M (414,814 @ $17.00) |
| Sep 28, 2026 | Orbimed Advisors LLC | Director | Buy | $5.1M (300,249 @ $17.00) |
| Sep 28, 2026 | OrbiMed Capital GP VII LLC | Director | Buy | $5.1M (300,249 @ $17.00) |
| Sep 28, 2026 | Simeon George | Insider | Buy | $10.1M (592,593 @ $17.00) |
| Sep 28, 2026 | Simeon George | Insider | Buy | $7.1M (414,814 @ $17.00) |
| Sep 28, 2026 | Sr One Capital Management, LLC | Insider | Buy | $10.1M (592,593 @ $17.00) |
| Sep 28, 2026 | OrbiMed Advisors Israel II Ltd | Director | Buy | $5.1M (300,249 @ $17.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.